Physicians Push Back on Treating COVID-19 as HAPE

Clara T. Fryman


What your doctor is reading on Medscape.com:

APRIL 21, 2020 — For Luanne Freer, MD, an expert in high-altitude pulmonary edema (HAPE) and founder and director of Everest ER, a nonprofit seasonal clinic at the Mt. Everest base camp in Nepal (elevation, 17,600 ft), a sudden flurry of messages and questions she received about a possible COVID-19/HAPE link was startling.

“That’s why it kind of poked me in the eye,” she said, referencing her extensive experience treating HAPE, which she described as a pressure-related phenomenon. “My goodness, they are so completely different.”


Dr. Freer,

Read More

Remdesivir & COVID Studies Find Different Results

Clara T. Fryman


By Dennis Thompson
HealthDay Reporter


WEDNESDAY, April 29, 2020 (HealthDay News) — Two new reports have produced conflicting results on the potential effectiveness of remdesivir, an experimental antiviral drug considered to be one of the leading hopes in the fight against COVID-19.

Disappointing results emerged from the first gold-standard clinical trial for remdesivir, which found that the drug did not help patients in China with severe COVID-19. Those findings were published April 29 in The Lancet medical journal.

On the same day, drugmaker Gilead Sciences announced positive early findings from a U.S.-designed clinical trial being

Read More

Interest in Unproven Drugs Follows Trump Thumbs Up

Clara T. Fryman


By Alan Mozes

HealthDay Reporter

WEDNESDAY, April 29, 2020 (HealthDay News) — When the President of the United States offers medical advice, many Americans will heed the call. Never mind that the recommendations may be unfounded and potentially dangerous.

That’s the cautionary finding of an analysis published April 29 in JAMA Internal Medicine.

Researchers examined Google search patterns following President Donald Trump’s public embrace of the malaria medications hydroxychloroquine and chloroquine as treatments for COVID-19.

“We monitored all Google searches indicative of shopping for chloroquine and hydroxychloroquine in the U.S. between February

Read More

Stephen Sherry, PhD, Selected as Acting Director, National Center for Biotechnology Information, National Library of Medicine

Clara T. Fryman

April 29, 2020

Stephen Sherry

National Library of Medicine Director, Patricia Flatley Brennan, RN, PhD, has named Stephen Sherry, PhD, as Acting Director, National Centre for Biotechnology Data (NCBI) at the National Library of Medicine (NLM) helpful March 31, 2020.

As Acting Director of NCBI, Dr. Sherry oversees a massive suite of on line means for biological info and knowledge, which include the GenBank® nucleic acid sequence databases and the PubMed databases of citations and abstracts for revealed lifestyle science journals. He is also accountable for producing and operating all NCBI output providers, with method areas spanning literature, sequences, chemistry, clinical analysis,

Read More

Subscribe US Now